What Happened?
Cambridge, MA-based Rgenta-Therapeutics Appointed Simon Xi as Co Founder and Chief Executive Officer
About the Company
Rgenta Therapeutics is developing a pipeline of oral, small-molecule RNA-targeting medicines with an initial focus on oncology and neurological disorders. Our proprietary platform mines the massive genomics data to identify targetable RNA processing events and design small-molecule glues to modulate the interactions among the spliceosome, regulatory proteins, and RNAs
About the Person
Simon Xi is Co Founder and Chief Executive Officer at Rgenta Therapeutics. Previously, Simon held various senior HR leadership roles in the industry.
Info Source
News
Short Profile